Cargando…
The role of ROS and subsequent DNA-damage response in PUMA-induced apoptosis of ovarian cancer cells
PUMA is a member of the “BH3-only” branch of the BCL-2 family. Our previous study suggests a therapeutic potential of PUMA in treating ovarian cancer, however, the action mechanism of PUMA remains elusive. In this work, we found that in PUMA adenovirus-infected A2780s ovarian cancer cells, exogenous...
Autores principales: | Yang, Jun, Zhao, Xinyu, Tang, Mei, Li, Lei, Lei, Yi, Cheng, Ping, Guo, Wenhao, Zheng, Yu, Wang, Wei, Luo, Na, Peng, Yong, Tong, Aiping, Wei, Yuquan, Nie, Chunlai, Yuan, Zhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410321/ https://www.ncbi.nlm.nih.gov/pubmed/28423586 http://dx.doi.org/10.18632/oncotarget.15626 |
Ejemplares similares
-
Caspase-9 mediates Puma activation in UCN-01-induced apoptosis
por: Nie, C, et al.
Publicado: (2014) -
BIM-Mediated AKT Phosphorylation Is a Key Modulator of Arsenic Trioxide-Induced Apoptosis in Cisplatin-Sensitive and -Resistant Ovarian Cancer Cells
por: Yuan, Zhu, et al.
Publicado: (2011) -
Mitochondrial p53 phosphorylation induces Bak-mediated and caspase-independent cell death
por: Wang, Jinjing, et al.
Publicado: (2015) -
6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death
por: Bernstein, Alison I, et al.
Publicado: (2011) -
The role of P53 up-regulated modulator of apoptosis (PUMA) in ovarian development, cardiovascular and neurodegenerative diseases
por: Li, Mei
Publicado: (2021)